Sionna Therapeutics is trading 6.2% down now at $5.86 after the broader biotech sector reversed Wednesday’s rally.
- Biotech ETF XBI is down 2.47% during the regular session, while major indexes are also modestly lower.
- No new company-specific announcement was identified for August 20, 2026.
- The earlier SION-719 Phase 2 setback remains important background but does not explain today’s sector-wide direction.